Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

IFN-α-2a (Interferon) and ribavirin induced suicidal attempt in a patient of chronic HCV: A rare case report.

Inder D, Rehan HS, Yadav M, Manak S, Kumar P.

Indian J Pharmacol. 2011 Apr;43(2):210-1. doi: 10.4103/0253-7613.77375.

3.

Psychiatric care of the patient with hepatitis C: a review of the literature.

Rifai MA, Gleason OC, Sabouni D.

Prim Care Companion J Clin Psychiatry. 2010;12(6). pii: PCC.09r00877. doi: 10.4088/PCC.09r00877whi.

4.
5.

Antiviral completion rates and sustained viral response in hepatitis C patients with and without preexisting major depressive disorder.

Hauser P, Morasco BJ, Linke A, Bjornson D, Ruimy S, Matthews A, Rifai A, Indest DW, Loftis JM.

Psychosomatics. 2009 Sep-Oct;50(5):500-5. doi: 10.1176/appi.psy.50.5.500.

6.

Major depressive disorder in hepatitis C: an open-label trial of escitalopram.

Gleason OC, Yates WR, Philipsen MA.

Prim Care Companion J Clin Psychiatry. 2005;7(5):225-30.

7.
8.

Neuropsychiatric adverse effects of interferon-alpha: recognition and management.

Raison CL, Demetrashvili M, Capuron L, Miller AH.

CNS Drugs. 2005;19(2):105-23. Review.

9.

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.

Sylvestre DL, Loftis JM, Hauser P, Genser S, Cesari H, Borek N, Kresina TF, Seeff L, Francis H.

J Urban Health. 2004 Dec;81(4):719-34.

Items per page

Supplemental Content

Write to the Help Desk